Cancer :: Fibrasorb – new device for cancer patients
A new device for cancer patients could end the side effects of chemotherapy such as hair loss and vomiting, researchers say.
A new device for cancer patients could end the side effects of chemotherapy such as hair loss and vomiting, researchers say.
Increased levels of dietary folate from food, but not from supplements, appears to reduce the risk of developing pancreatic cancer, according to results of a large population-based study of Swedish men and women.
For women with genetic mutations that increase their risk of breast and ovarian cancer, genetic testing has been a godsend. The tests allow them to learn if they carry mutations in the BRCA 1 and BRCA 2 genes, and if they do, to decide what action to take, such as stepping up screening or undergoing a preventive mastectomy.
African American women are more likely to die from breast cancer, and minorities in general do not receive the best treatment for the disease compared with white women, according to two studies published in the Journal of Clinical Oncology.
The Food and Drug Administration (FDA) announced the approval of Erbitux (cetuximab) for use in combination with radiation therapy to treat patients with squamous cell cancer of the head and neck (SCCHN) that can not be removed by surgery (unresectable SCCHN). This is the first drug approved for head and neck cancer that has shown a survival benefit in this population. Erbitux was also approved today for use alone (monotherapy) to treat patients whose head and neck cancer has spread (metastasized) despite the use of standard chemotherapy.
The Food and Drug Administration (FDA), the National Cancer Institute (NCI), part of the National Institutes of Health, and the Centers for Medicare & Medicaid Services (CMS) today announced the Oncology Biomarker Qualification Initiative (OBQI) — an agreement to collaborate on improving the development of cancer therapies and the outcomes for cancer patients through biomarker development and evaluation.
Magnetic resonance imaging or an MRI is usually used to locate unseen problems dealing with the head, neck, spine and extremities.
Drinking five cups of green tea a day can reduce the risk of breast cancer by 22 per cent, claims a meta-analysis of previous studies, the same studies that the FDA recently said contained very little science to support the claims.
Studies suggest that a growing number of cancer patients supplement their treatment with alternative remedies, and Essiac is high on the list.
Women with breast implants who are in an age group where routine mammograms are recommended should be sure to have these examinations at the recommended regularly scheduled times.